The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Berns A.S.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Chebotareva N.V.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Sovetnikov E.N.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Kraeva V.V.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Rodionov I.V.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Devyataykina A.S.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Moiseev S.V.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Assessment of hemostasis disorders using thromboelastography in patients with chronic glomerulonephritis and nephrotic syndrome

Authors:

Berns A.S., Chebotareva N.V., Sovetnikov E.N., Kraeva V.V., Rodionov I.V., Devyataykina A.S., Moiseev S.V.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2022;25(1): 84‑90

Read: 2925 times


To cite this article:

Berns AS, Chebotareva NV, Sovetnikov EN, Kraeva VV, Rodionov IV, Devyataykina AS, Moiseev SV. Assessment of hemostasis disorders using thromboelastography in patients with chronic glomerulonephritis and nephrotic syndrome. Russian Journal of Preventive Medicine. 2022;25(1):84‑90. (In Russ.)
https://doi.org/10.17116/profmed20222501184

Recommended articles:

References:

  1. Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res. 2006; 118(3):397-407.  https://doi.org/10.1016/j.thromres.2005.03.030
  2. Fahal IH, McClelland P, Hay CR, Bell GM. Arterial thrombosis in the nephrotic syndrome. Postgrad Med J. 1994;70(830):905-909.  https://doi.org/10.1136/pgmj.70.830.905
  3. Panteleev MA, Ataullakhanov FI. Blood clotting: biochemical bases. Clinical oncohematology. 2008;1(1):50-62. (In Russ.).
  4. Panteleev MA, Hemker HC. Global/integral assays in hemostasis diagnostics: Promises, successes, problems and prospects. Thrombosis Journal. 2015; 13(1):1-4.  https://doi.org/10.1186/s12959-014-0032-y
  5. Stomenskaya IS, Kostrova OYu, Struchko GYu, Timofeeva NY. Thromboelastometry is a method of laboratory diagnostics of disorders of the hemostasis system. Medical almanac. 2017;2(47):96-98. (In Russ.).
  6. Avdushkina LA, Vavilova TV, Zybina NN. The method of thromboelastography/thromboelastometry in the assessment of the hemostasis system: past and present. Reference intervals. Clinical and laboratory consultation. 2009; 5:26-33. (In Russ.).
  7. Grinevich TN. Rotational thromboelastography ROTEM as a new promising method for assessing the hemostasis system in patients with a traumatological profile. News of surgery. 2010;2(18):111-121. (In Russ.).
  8. Bulanov AYu. Thromboelastography in modern clinical practice. Atlas TAG. M.: Newdiamed; 2015. (In Russ.).
  9. Mahmoodi BK, Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L, Navis G, van der Meer J. High Absolute Risks and Predictors of Venous and Arterial Thromboembolic Events in Patients With Nephrotic Syndrome: Results From a Large Retrospective Cohort Study. Circulation. 2008;117(2):2 24-230.  https://doi.org/10.1161/circulationaha.107.716951
  10. Hofstra JM, Wetzels JFM. Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy? Kidney Int. 2016;89(5):981-983.  https://doi.org/10.1016/j.kint.2016.01.019
  11. Curry ANG, Pierce JMT. Conventional and near-patient tests of coagulation. Continuing Education in Anaesthesia, Critical Care and Pain. 2007; 7(2):45-50.  https://doi.org/10.1093/bjaceaccp/mkm002
  12. Sexton DJ, Clarkson MR, Mazur MJ, Plant WD, Eustace JA. Serum D-dimer concentrations in nephrotic syndrome track with albuminuria, not estimated glomerular filtrationrate. Am J Nephrol. 2012;36(6):554-560.  https://doi.org/10.1159/000345475
  13. Gyamlani G, Molnar MZ, Lu JL, Sumida K, Kalantar-Zadeh K, Kovesdy CP. Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome. Nephrol Dial Transplant. 2017;32(1):157-164.  https://doi.org/10.1093/ndt/gfw227
  14. Glassock RG. Prophylactic anticoagulation in nephrotic syndrome: A clinical conundrum. J Am Soc Nephrol. 2007;18(8):2221-2225. https://doi.org/10.1681/ASN.2006111300
  15. Cherng SC, Huang WS, Wang YF, Yang SP, Lin YF. The role of lung scintigraphy in the diagnosis of nephrotic syndrome with pulmonary embolism. Clin Nucl Med. 2000;25(3):167.  https://doi.org/10.1097/00003072-200003000-00001
  16. Kuhlmann U, Steurer J, Bollinger A, Pouliadis G, Briner J, Siegenthaler W. Incidence and clinical significance of thromboses and thrombo-embolic complications in nephrotic syndrome patients. Schweiz Med Wochenschr. 1981;111(27-28):1034-1040.
  17. Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D’Agati V, Appel G. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007;2(3):445-453.  https://doi.org/10.2215/CJN.03531006
  18. Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res. 2006; 118(3):397-407.  https://doi.org/10.1016/j.thromres.2005.03.030
  19. Roy C, Deschaintre Y, Sabbagh R, Roy D, Cardinal H, Bollée G. Ischemic stroke of possible embolic etiology associated with nephritic syndrome. Kidney Int Rep. 2017;2(5):988-994.  https://doi.org/10.1016/j.ekir.2017.04.004
  20. Lionaki S. Venous Thromboembolism in Patients with Membranous Nephropathy. Clin J Am Soc Nephrol. 2012;7(1):43-51.  https://doi.org/10.2215/CJN.04250511
  21. Hamano K, Iwano M, Akai Y, et al. Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis. Am J Kidney Dis. 2002; 39(4):695-705.  https://doi.org/10.1053/ajkd.2002.31986
  22. Beltrami E, Jesty J. The role of membrane patch size and flow in regulating a proteolytic feedback threshold on a membrane: possible application in blood coagulation. Mathematical Biosciences. 2001;172(1):1-13.  https://doi.org/10.1016/s0025-5564(01)00064-5
  23. Owens AP 3rd, Passam FH, Antoniak S, Marshall SM, McDaniel AL, Rudel L, Williams JC, Hubbard BK, Dutton JA, Wang J, Tobias PS, Curtiss LK, Daugherty A, Kirchhofer D, Luyendyk JP, Moriarty PM, Nagarajan S, Furie BC, Furie B, Johns DG, Temel RE, Mackman N. Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest. 2012;122(2):558-568.  https://doi.org/10.1172/JCI58969
  24. Huang MJ, Wei RB, Wang ZC, ing Y, Gao YW, Li MX, Cai GY, Chen XM. Mechanisms of hypercoagulability in nephrotic syndrome associated with membranous nephropathy as assessed by thromboelastography. Thromb Res. 2015;136(3):663-668.  https://doi.org/10.1016/j.thromres.2015.06.031

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.